Differential changes of nicotinic receptors in the rat brain following ibotenic acid and 192-IgG saporin lesions of the nucleus basalis magnocellularis

International Journal of Developmental Neuroscience

Volumn 16, Issue 7-8, 1998, Pages 661-668

  Bednar, Ivan ^a   Zhang, Xiao ^a   Dastranj Sedghi, Ramez ^a   Nordberg, Agneta ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

192 IgG saporin; 3H cytisine; 3H epibatidine; Animal model; Ibotenic acid; Lesion; Nicotinic acetylcholine receptor; Nucleus basalis magnocellularis

Indexed keywords

IBOTENIC ACID; IMMUNOTOXIN; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DISEASE MODEL; MAGNOCELLULAR NUCLEUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR BINDING; RECEPTOR DENSITY;

ANIMALIA;

EID: 0032454597     PISSN: 07365748     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0736-5748(98)00076-8     Document Type: Article

References (47)

1. Altman, H. J., Crosland, R. D., Jenden, D. J. and Berman, R. F., Further characterizations of the nature of the behavioral and neurochemical effects of lesions to the nucleus basalis of Meynert in the rat. Neurobiol. Aging, 1985, 6, 125-130.
2. Baxter, M. G., Bucci, D. J., Gorman, L. K., Wiley, R. G. and Gallagher, M., Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats. Behav. Neurosci., 1995, 109, 714-722.
3. Badio, B. and Daly, J., Epibatidine, a potent analgesic and nicotinic agonist. Mol. Pharmacol., 1994, 45, 563-569.
4. Bartus, R. T., Dean III, R. L., Beer, B. and Lippa, A. S., The cholinergic hypothesis of geriatric memory dysfunction. Science, 1982, 217, 408-417.
5. Berger-Sweeney, J., Heckers, S., Mesulam, M. M., Wiley, R. G., Lappi, D. A. and Sharma, M., Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis. J. Neurosci., 1994, 14, 4507-4519.
6. Book, A. A., Wiley, R. G. and Schweitzer, J. B., 192-IgG saporin: I. Specific lethality for cholinergic neurons in the basal forebrain of the rat. J. Neuropath. Exp. Neurol., 1994, 53, 95-102.
7. Brioni, J. D., Decker, M. W., Sullivan, J. P. and Arneric, S. P., The pharmacology of (-)-nicotine and novel cholinergic channel modulators. Adv. Pharmacol., 1997, 37, 153-214.
8. Casamenti, F., Bracco, L., Bartolini, L. and Papeu, G., Unilateral and bilateral nucleus basalis lesions: difference in neurochemical and behavioural recovery. Neurosci., 1988, 24, 209-215.
9. Dornan, W. A., McCampbell, A. R., Tinkler, G. P., Hickman, L. J., Bannon, A. W., Decker, M. W. and Gunther, K. L., Comparison of site-specific injections into the basal forebrain on water maze and radial arm maze performance in the male rat after immunolesioning with 192 IgG saporin. Behav. Brain res., 1996, 82, 93-101.
10. Dunnett, S. B., Whishaw, I. Q., Jones, G. H. and Bunch, S. T., Behavioural, biochemical and histochemical effects of different neurotoxic amino acids injected into nucleus basalis magnocellularis of rats. Neurosci., 1987, 20, 653-669.
11. El-Defrawy, S. R., Boegman, R. J., Jhamandas, K., Beninger, R. J. and Shipton, L., Lack of recovery of cortical cholinergic function following quinolinic or ibotenic acid injections into the nucleus basalis magnocellularis in rats. Exp. Neurol., 1986, 91, 628-633.
12. Flores, C. M., Rogers, S. W., Pabreza, L. A., Wolfe, B. B. and Kellar, K. J., A subtype of nicotinic cholinergic receptor in rat brain is composed of α4 and β2 subunits and is up-regulated by chronic nicotine treatment. Mol. Pharmacol., 1992, 41, 31-37.
13. Flores, C. M., DeCamp, R. M., Kilo, S., Rogers, S. W. and Hargreaves, K. M., Neuronal nicotinic receptor expression in sensory neurons of the rat trigeminal ganglion: demonstration of α3β4, a novel subtype in the mammalian nervous system. J. Neurosci., 1996, 16, 7892-7901.
14. Flores, C. M., Davila-Garcia, M. I., Ulrich, Y. M. and Kellar, K., Differential regulation of neuronal nicotinic binding sites following chronic nicotine administration. J. Neurochem., 1997, 69, 2216-2219.
15. Games, D., Adams, D., Alessanndrini, R., Barbour, R., Berhelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F. et al., Alzheimer-type neuropathology in transgenic mice overexpressing V717F 3-amyloid precusor protein. Nature, 1995, 373, 523-527.
16. Gotti, C., Fornasari, D. and Clementi, F., Human neuronal nicotinic receptors. Progr. Neurobiol., 1997, 53, 199-237.
17. 3H]epibatidine binding to nicotinic cholinergic receptors in rat and human brain. Mol. Pharmacol., 1995, 48, 280-287.
18. Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F. and Cole, G., Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science, 1996, 274, 99-102.
19. Irizarry, M. C., Soriano, F., McNamara, M., Page, K. J., Schenk, D., Games, D. and Hyman, B. T., Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the PDAPP transgenic mice. J. Neurosci., 1997, 17, 7053-7059.
20. Lapchak, P. A., Araujo, D. M., Pasinetti, G. and Hefti, F., Differential alterations of cortical cholinergic and neurotensin markers following ibotenic acid lesions of the nucleus basalis magnocellularis. Brain Res., 1993, 613, 239-246.
21. Lin, L., LeBlanc, C., Deacon, T. W. and Isacson, O., Chronic cognitive deficits and amyloid precusor protein elevation after selective immunotoxin lesions of the basal forebrain cholinergic system. NeuroReport, 1998, 9, 547-552.
22. Lowry, O. H., Rosenbrough, N. J., Farr, A. L. and Randall, R. J., Protein measurement with the Folin phenol reagent. J. Biol. Chem., 1951, 193, 265-275.
23. Miyai, I., Ueno, S., Yorifuji, H., Fujimura, H. and Tauri, S., Alternations in neocortical expression of nicotinic acetylcholine receptor mRNAs following unilateral lesions of the nucleus basalis magnocellularis. J. Neural Transm., 1990, 82, 79-91.
24. Nordberg, A., Larsson, C., Perdahl, E. and Winblad, B., Cholinergic activity in hippocampus in chronic alcoholism. Drug Alcohol Dep., 1982, 10, 33-34.
25. Nordberg, A. and Winblad, B., Reduced number of 3H-nicotine and 3H-acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci. Lett., 1986b, 72, 115-119.
26. Nordberg, A., Adem, A., Hardy, J. and Winblad, B., Changes in nicotinic receptor subtypes in temporal cortex of Alzheimer brains. Neurosci. Lett., 1988, 86, 317-321.
27. 11C-nicotine in brain of Alzheimer patients as visualised by positron emission tomography. J. Neural. Transm., 1990, 2, 215-224.
28. Nordberg, A., Lundqvist, H., Hartvig, P., Lilja, A. and Långström, B., Kinetic analysis of regional (S)(-)11C-nicotine binding in normal and Alzheimer brains. Alzheim. Dis. Assoc. Dosord., 1995, 9, 21-21.
29. Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates. Academic Press, New York, 1986.
30. Riekkinen Jr., P., Riekkinen, M., Sirvio, J., Miettinen, R. and Riekkinen, P., Comparison of the effects of acute and chronic ibotenic and quiaqualic acid nucleus basalis lesioning. Brain Res. Bull., 1991, 27, 199-206.
31. Roßner, S., Schliebs, R., Härtig, W. and Bigl, V., 192IgG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus. Brain Res. Bull., 1995a, 38, 371-381.
32. Roßner, S., Schliebs, R. and Bigl. V., 192IgG-saporin-induced immunotoxic lesions of cholinergic basal forebrain system differentially affect glutamatergic and GABAergic markers in cortical rat brain regions. Brain Res., 1995b, 696, 165-176.
33. Roßner, S., Schliebs, R., Perez-Polo, J. R., Wiley, R. G. and Bigl, V., Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system. J. Neurosci. Res., 1995d, 40, 31-43.
34. Sahakian, B., Jonnes, G., Levy, R., Gray, J. and Warburton, D., The effects of nicotine on attention, information processing and short-term memory in patients with dementia of Alzheimer type. Br. J. Psychiatry, 1989, 154, 797-800.
35. Smith, M. A., Hirai, K., Hsioa, K., Pappolla, M. A., Harris, P. L. R., Siedlak, S. L., Tabaton, M. and Perry, G., Amyloid-β deposition in Alzheimer transgenic mice is associated with oxidative stress. J. Neurochem., 1998, 70, 2212-2215.
36. Torres, E. M., Perry, T. A., Blokland, A., Wilkinson, L. S., Wiley, R. G., Lappi, D. A. and Dunnett, S. B., Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience, 1994, 63, 95-122.
37. Vige, X. and Briely, M., Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats. Neurosci. Lett., 1988, 88, 319-324.
38. Warburton, D. M., Rusted, J. M. and Fowler, J., A comparison of the attential and consolidation hypothesis for the facilitation of memory by nicotine. Psychopharmacol., 1992, 108, 443-447.
39. Warpman, U. and Nordberg, A., Epibatidine and ABT-418 reveal selective loss of α4β2 nicotinic receptors in Alzheimer brains. NeuroReport, 1995, 6, 2419-2423.
40. Wenk, G. L. and Olton, D. S., Recovery of neocortical choline acetyltransferase activity following ibotenic acid injections in the nucleus basalis of Meynert in rats. Brain Res., 1984, 293, 184-186.
41. Wenk, G. L., Stoehr, J. D., Quintana, G., Mobley, S. and Wiley, R. G., Behavioral, biochemical, histological, and electrophysiological effects of 192 IgG-saporin injections into basal forebrain of rats. J. Neurosci., 1994, 14, 5986-5995.
42. Whitehouse, P. J., Price, D. L., Struble, F. G., Clark, A. W., Coyle, J. T. and DeLong, M. R., Alzheimers disease and senile dementia: loss of the neurons in the basal forebrain. Science, 1982, 215, 1237-1239.
43. Whitehouse, P. J., Martino, A. M., Antuono, P. G., Lowenstein, P. R., Coyle, J. T., Price, D. L. and Kellar, K. J., Nicotinic acetylcholine binding sites in Alzheimer's disease. Brain Res., 1986, 371, 146-151.
44. Wiley, R. G., Berbos, T. G., Deckwerth, T. L., Johnson Jr. E. M. and Lappi, D. A., Destruction of the cholinergic basal forebrain using immunotoxin to rat NGF receptor: modeling the cholinergic degeneration of Alzheimer's disease. J. Neurolog. Sci., 1995, 128, 157-166.
45. Wonnacott, S., Presynaptic nicotinic ACh receptors. Trends Neurosci., 1997, 20, 92-98.
46. Zawia, N., Arendash, G. W. and Wecker, L., Basal forebrain cholinergic neurons in aged rat brain are more susceptible to ibotenate-induced degeneration than neurons in young adult brain. Brain Res., 1992, 589, 333-337.
47. Zhang, X., Gong, Z.-H., Fasth, K. J., Långström, B. and Nordberg, A., Interaction of the nicotinic agonist (R, S)-3-pyridyl-1-methyl-2-(3-pyridyl)-azetidine (MPA) with nicotinic acetylcholine receptor subtypes expressed in cell lines and rat cortex. Neutochem. Int., 1998, 32, 435-441.